737328

AstraZeneca Pharmaceuticals, LP — FEI 2517100

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 5, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Newark, DE (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures